Get notified when MMED files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Controlled Company (new) — Medtronic will retain over 90% voting power, so MiniMed qualifies as a controlled company and can opt out of certain Nasdaq governance requirements.
MiniMed Group prices IPO at $20/share, raising $537.6M before expenses; Medtronic keeps 90% voting control
Filed March 6, 2026 · ~1 min read
Key Changes
-
high
MiniMed Group is offering 28,000,000 shares at $20.00 per share, raising $537.6 million before expenses for the company.
The Offering verify on EDGAR → -
high
After underwriting discounts of $0.80 per share, net proceeds to MiniMed are $19.20 per share, or $537.6 million before expenses.
The Offering verify on EDGAR → -
high
Medtronic will retain 90.03% of voting power after the offering (88.70% if underwriters exercise the over-allotment option).
The Offering verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (SNX 10-Q) is open in full — no account needed.
Partner
Trade MMED commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify